disorders of lipid metabolism	is a	metabolic disease
disorders of lipid metabolism	involves	cholesterol
disorders of lipid metabolism	involves	triglycerides
disorders of lipid metabolism	causes	atherosclerosis
disorders of lipid metabolism	leads to	coronary artery disease
disorders of lipid metabolism	leads to	stroke
disorders of lipid metabolism	leads to	peripheral artery disease
disorders of lipid metabolism	increases	LDL
disorders of lipid metabolism	decreases	HDL
disorders of lipid metabolism	increases	VLDL
disorders of lipid metabolism	increases	lipoprotein(a)
disorders of lipid metabolism	is associated with	obesity
disorders of lipid metabolism	is associated with	insulin resistance
disorders of lipid metabolism	is associated with	type 2 diabetes
disorders of lipid metabolism	is associated with	metabolic syndrome
disorders of lipid metabolism	is associated with	non‑alcoholic fatty liver disease
disorders of lipid metabolism	is associated with	pancreatitis
disorders of lipid metabolism	is associated with	gout
disorders of lipid metabolism	is associated with	hypertension
disorders of lipid metabolism	is associated with	chronic kidney disease
disorders of lipid metabolism	is diagnosed by	fasting lipid panel
disorders of lipid metabolism	is diagnosed by	lipid profile
disorders of lipid metabolism	is diagnosed by	apolipoprotein B test
disorders of lipid metabolism	is diagnosed by	lipoprotein(a) assay
disorders of lipid metabolism	is diagnosed by	genetic testing
disorders of lipid metabolism	is treated with	statins
disorders of lipid metabolism	is treated with	ezetimibe
disorders of lipid metabolism	is treated with	bile acid sequestrants
disorders of lipid metabolism	is treated with	PCSK9 inhibitors
disorders of lipid metabolism	is treated with	fibrates
disorders of lipid metabolism	is treated with	niacin
disorders of lipid metabolism	is treated with	omega‑3 fatty acids
disorders of lipid metabolism	is treated with	lifestyle modification
statins	lower	LDL
statins	reduce	cardiovascular events
statins	increase	HDL
statins	cause	myopathy
statins	cause	hepatotoxicity
ezetimibe	blocks	NPC1L1
ezetimibe	lowers	LDL
bile acid sequestrants	bind	bile acids
bile acid sequestrants	lower	LDL
PCSK9 inhibitors	inhibit	PCSK9
PCSK9 inhibitors	lower	LDL
PCSK9 inhibitors	reduce	plaque burden
fibrates	activate	PPARα
fibrates	lower	triglycerides
fibrates	raise	HDL
niacin	raises	HDL
niacin	lowers	triglycerides
omega‑3 fatty acids	lower	triglycerides
omega‑3 fatty acids	reduce	inflammation
lifestyle modification	includes	diet
lifestyle modification	includes	exercise
lifestyle modification	includes	weight loss
diet	reduces	saturated fat
diet	reduces	trans fat
diet	increases	fiber
exercise	improves	insulin sensitivity
exercise	reduces	LDL
exercise	increases	HDL
weight loss	reduces	triglycerides
weight loss	reduces	LDL
weight loss	increases	HDL
obesity	increases	LDL
obesity	increases	triglycerides
obesity	decreases	HDL
insulin resistance	increases	triglycerides
insulin resistance	increases	LDL
insulin resistance	decreases	HDL
type 2 diabetes	increases	cardiovascular risk
type 2 diabetes	increases	atherosclerosis
metabolic syndrome	includes	hypertension
metabolic syndrome	includes	hyperglycemia
metabolic syndrome	includes	central obesity
metabolic syndrome	includes	dyslipidemia
non‑alcoholic fatty liver disease	is a	hepatic steatosis
non‑alcoholic fatty liver disease	is associated with	insulin resistance
non‑alcoholic fatty liver disease	increases	cardiovascular risk
pancreatitis	can be caused by	hypertriglyceridemia
gout	is associated with	hyperuricemia
gout	is associated with	hyperlipidemia
hypertension	is a	cardiovascular risk factor
hypertension	is treated with	ACE inhibitors
hypertension	is treated with	ARBs
hypertension	is treated with	calcium channel blockers
chronic kidney disease	worsens	lipid profile
chronic kidney disease	is a	risk factor for	atherosclerosis
lipid profile	predicts	cardiovascular risk
lipid profile	predicts	mortality
lipid profile	predicts	readmission
statins	reduce	all‑cause mortality
statins	reduce	cardiovascular mortality
PCSK9 inhibitors	reduce	LDL‑related mortality
fibrates	reduce	pancreatitis risk
omega‑3 fatty acids	reduce	sudden cardiac death
dietary fiber	reduces	LDL
dietary fiber	reduces	triglycerides
exercise	reduces	blood pressure
exercise	reduces	insulin resistance
